Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,149.30
+3.70 (0.32%)
Feb 18, 2026, 3:10 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 119.85 billion as of February 18, 2026. Its market cap has decreased by -44.16% in one year.
Market Cap
119.85B
Enterprise Value
116.54B
Revenue
11.59B
Ranking
n/a
PE Ratio
38.59
Stock Price
1,149.30
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 119.85B, an increase of 21.51%. That is a compound annual growth rate of 8.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 119.85B | -14.86% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 611.66B |
| Anthem Biosciences | 387.48B |
| OneSource Specialty Pharma | 135.85B |
| Blue Jet Healthcare | 68.92B |
| Supriya Lifescience | 54.80B |
| Zota Health Care | 47.55B |
| Dishman Carbogen Amcis | 31.63B |
| Panacea Biotec | 21.44B |